| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/21/2006 | US7001905 Substituted diarylamines as MEK inhibitors |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2065986C 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments |
| 02/16/2006 | WO2006016725A1 Photosensitive heterocyclic azo compound, process for producing the same, and optical information recording medium |
| 02/16/2006 | WO2006016724A2 Liquid-crystalline compounds, compositions and thin films |
| 02/16/2006 | WO2006016237A2 Heterocyclic derivatives as anti-inflammatory agents |
| 02/16/2006 | WO2006015986A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | WO2006015854A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 02/16/2006 | WO2006015851A1 Piperazine derivatives with ccr3 inhibiting activity |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005112916A3 Bis-aryl sulfonamides |
| 02/16/2006 | WO2005105739A3 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 02/16/2006 | WO2005082900A3 Oxazolidinone amidoximes as antibacterial agents |
| 02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | US20060035945 Prevent reproduction, infection of virus; antitumor agents |
| 02/16/2006 | US20060035943 E.g., 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 02/16/2006 | US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase |
| 02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035896 Inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening and therapy |
| 02/16/2006 | US20060035895 Isoxazoline derivatives useful as antimicrobials |
| 02/16/2006 | US20060035894 Phenyl[(2S)-4-(phenylmethyl)morpholin-2-yl]methanol; anxiolytic, antidepressant, cognition activator; rise in the concentration of that neurotransmitter within the synaptic cleft; psycological disorders, attention deficit hyperactivity disorder, obesity; deprotection |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | US20060035838 Drug therapy for celiac sprue |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2576041A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 02/16/2006 | CA2575702A1 Oxindole oxazolidinones as antibacterial agents |
| 02/16/2006 | CA2574292A1 Piperazine derivatives with ccr3 inhibiting activity |
| 02/16/2006 | CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | CA2572748A1 Organic compounds |
| 02/15/2006 | EP1625124A1 Oxazolidinone derivatives as antimicrobials |
| 02/15/2006 | EP1625123A2 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/15/2006 | EP1625120A1 Chemical compounds |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | CN1735610A Oxazoles as mGluR1 enhancer |
| 02/15/2006 | CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | CN1735603A Benzomorpholine derivatives |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1733760A Phenolphthalein type benzoxazine intermediate and composition and method of making the same |
| 02/15/2006 | CN1733735A N-2-pyrimidinyl oxy-benzyl substituted cyclic amine compound, its preparation process and uses |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/14/2006 | US6998420 Oxazolidinone compounds |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998412 Heterocyclic compounds |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/14/2006 | CA2241186C Benzimidazole derivatives |
| 02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
| 02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
| 02/09/2006 | WO2006014185A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/09/2006 | WO2006014005A1 Pyrazole derivative |
| 02/09/2006 | WO2006013049A2 Benzyloxy derivatives as maob inhibitors |
| 02/09/2006 | WO2006012982A1 Dioxazinyl-substituted thienylsulphonylaminocarbonyl compounds |
| 02/09/2006 | WO2005118558A3 Pyrimidine compounds and use thereof |
| 02/09/2006 | WO2005118511A3 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 02/09/2006 | WO2005112913B1 Transthyretin stabilization |
| 02/09/2006 | WO2005095409A3 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/09/2006 | WO2005086898A3 Inhibitors of histone deacetylase |
| 02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030609 Oxazolidinones containing oxindoles as antibacterial agents |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | US20060030559 Diazole derivatives |
| 02/09/2006 | US20060030558 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2578261A1 Pyrazole derivative |
| 02/09/2006 | CA2576028A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 02/09/2006 | CA2575340A1 Macrocyclic beta-secretase inhibitors |
| 02/09/2006 | CA2575326A1 Dioxazinyl-substituted thienylsulphonylaminocarbonyl compounds |
| 02/09/2006 | CA2575018A1 Benzyloxy derivatives as maob inhibitors |
| 02/09/2006 | CA2574966A1 Isoindoline compounds and methods of their use |
| 02/09/2006 | CA2573063A1 Compounds useful for inhibiting chk1 |
| 02/09/2006 | CA2555566A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/08/2006 | EP1623983A1 Heterocyclic compounds useful as DPP-IV inhibitors |
| 02/08/2006 | EP1622896A1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 02/08/2006 | EP1622616A2 Inhibitors of akt activity |
| 02/08/2006 | EP1622615A2 Naphthyridine integrase inhibitors |
| 02/08/2006 | EP1622610A1 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 02/08/2006 | EP0812318B1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732159A 2-oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 02/08/2006 | CN1731994A Prophylactic and therapeutic agent for neuropathy |
| 02/08/2006 | CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |